Express Scripts Holding Company (NASDAQ:ESRX) – Equities researchers at SunTrust Banks lowered their FY2017 earnings estimates for shares of Express Scripts Holding in a report issued on Wednesday, Zacks Investment Research reports. SunTrust Banks analyst D. Macdonald now forecasts that the company will earn $7.03 per share for the year, down from their prior forecast of $7.04. SunTrust Banks also issued estimates for Express Scripts Holding’s Q1 2018 earnings at $1.46 EPS, Q2 2018 earnings at $1.88 EPS, Q3 2018 earnings at $2.05 EPS, Q1 2019 earnings at $1.58 EPS and Q2 2019 earnings at $2.02 EPS.
ESRX has been the subject of a number of other research reports. Needham & Company LLC began coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating for the company. BidaskClub cut shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Morgan Stanley increased their price target on shares of Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research report on Thursday, August 10th. Jefferies Group LLC set a $72.00 price target on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Finally, Robert W. Baird reaffirmed a “hold” rating and set a $56.00 price objective on shares of Express Scripts Holding in a research report on Friday, September 1st. Seven equities research analysts have rated the stock with a sell rating, ten have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $69.53.
COPYRIGHT VIOLATION WARNING: This article was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://stocknewstimes.com/2017/11/11/equities-analysts-set-expectations-for-express-scripts-holding-companys-fy2017-earnings-esrx.html.
Shares of Express Scripts Holding (NASDAQ:ESRX) traded down $0.70 during mid-day trading on Thursday, hitting $60.05. 3,608,400 shares of the stock traded hands, compared to its average volume of 4,115,587. The stock has a market capitalization of $34,407.16, a P/E ratio of 8.88, a PEG ratio of 0.90 and a beta of 0.88. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a fifty-two week low of $55.80 and a fifty-two week high of $77.50.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.90. The company had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. Express Scripts Holding’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.74 earnings per share.
Several institutional investors and hedge funds have recently modified their holdings of ESRX. Zeke Capital Advisors LLC grew its stake in Express Scripts Holding by 85.4% during the third quarter. Zeke Capital Advisors LLC now owns 12,347 shares of the company’s stock worth $782,000 after purchasing an additional 5,688 shares during the period. Twin Capital Management Inc. grew its stake in Express Scripts Holding by 79.5% during the third quarter. Twin Capital Management Inc. now owns 83,207 shares of the company’s stock worth $5,269,000 after purchasing an additional 36,857 shares during the period. Cadence Capital Management LLC acquired a new stake in Express Scripts Holding during the third quarter worth approximately $1,550,000. Marshall & Sullivan Inc. WA grew its stake in Express Scripts Holding by 4.1% during the third quarter. Marshall & Sullivan Inc. WA now owns 41,102 shares of the company’s stock worth $2,519,000 after purchasing an additional 1,615 shares during the period. Finally, Schroder Investment Management Group grew its stake in Express Scripts Holding by 12.1% during the third quarter. Schroder Investment Management Group now owns 2,314,162 shares of the company’s stock worth $145,954,000 after purchasing an additional 248,883 shares during the period. Institutional investors own 90.30% of the company’s stock.
In related news, CEO Timothy C. Wentworth bought 8,000 shares of Express Scripts Holding stock in a transaction dated Tuesday, October 31st. The shares were bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the acquisition, the chief executive officer now owns 98,628 shares in the company, valued at approximately $6,029,129.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the sale, the director now directly owns 11,500 shares in the company, valued at $735,195. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,284 shares of company stock worth $397,421. Insiders own 0.68% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.